20 octobre 2016:Prof. Joan Montaner
Jeudi 20 octobre 2016, 12h30
CMU - C150
«Use of biomarkers in clinical practice is getting popular among physicians to aid making diagnostic and prognostic decisions. In certain areas of biomedicine, biomarker analysis has been incorporated to daily-practice (i.e.the diagnosis of acute myocardial infarction ,troponins). Recently there has been a great interest for their use in neurovascular diseases to help physicians in various stages of the evaluation of stroke, from predicting the risk of suffering a stroke among healthy individuals to getting the biochemical diagnosis of stroke or using biomarkers as tools for outcome prediction. Dr Joan Montaner, neurologist, director of the Neurovascular Research Laboratory at the Vall d’Hebron Research Institute (VHIR) as well the Director of the Stroke Programme, IBIS-HVR-HVM, in Sevilla has one of the most active groups in translational research in the field of stroke biomarkers.»
Prof. Jean-Charles Sanchez and Dr Natacha Turck, Hosts
Department of Human protein Sciences, Faculté de Médecine, UNIGE
__________________________________________________
Joan MONTANER MD,PhD
Neurovascular Research Lab Director,
Vall d’Hebron Institute of Research (VHIR) Barcelona & Stroke Program Director, IBIS-HVM-HVR, Seville
